MedPath

Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold

Not Applicable
Completed
Conditions
Coronary Artery Disease
Ischemic Heart Disease
Stable Angina
Acute Myocardial Infarction
Unstable Angina
Registration Number
NCT02162056
Lead Sponsor
University of Ulm
Brief Summary

To evaluate the safety, performance and efficacy of the bioresorbable vascular scaffold (BVS) system in patients with coronary artery disease

Detailed Description

Patients with coronary artery disease receive bioabsorbable vascular scaffolds. Patients are clinically followed during a period of 10 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
326
Inclusion Criteria
  • coronary artery disease
  • implantation of at least one bioresorbable vascular scaffold
Exclusion Criteria
  • no written informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Major Adverse Cardiac Events10 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Ulm

🇩🇪

Ulm, Germany

University of Ulm
🇩🇪Ulm, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.